Clinical trials: Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms
- Condition Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Prostatic Hyperplasia
The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)
Study to assess efficacy, tolerability and safety parameters of a three month ALNA®OCAS® -treatment with special respect to nocturia
- Trial name
- NCT02245542
- Testing
- ALNA®OCAS®
- Volunteers
- 5,775 people
- Sponsor
- Boehringer Ingelheim